Filing Details

Accession Number:
0001396677-13-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-06 16:32:18
Reporting Period:
2013-05-02
Filing Date:
2013-05-06
Accepted Time:
2013-05-06 16:32:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1050007 Nutraceutical International Corp NUTR Medicinal Chemicals & Botanical Products (2833) 870515089
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1265855 E Stanley Soper C/O Nutraceutical International Corp
1400 Kearns Blvd 2Nd Fl.
Park City UT 84060
Vp, Legal Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-02 202 $17.79 17,829 No 4 A Indirect By Trust
Common Stock Acquisiton 2013-05-03 2,500 $12.32 20,329 No 4 M Indirect By Trust
Common Stock Disposition 2013-05-03 2,500 $18.46 17,829 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Indirect By Trust
No 4 M Indirect By Trust
No 4 S Indirect By Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-05-03 2,500 $0.00 2,500 $12.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,500 2013-12-17 No 4 M Indirect
Footnotes
  1. The purchase reported in this Form 4 was effected pursuant to an enrollment plan under the issuer's Stock Purchase Plan for Employees, Stakeholders and Shareholders adopted by the reporting person on February 7, 2013.
  2. These shares are held in The Soper Family Trust (the "Trust"), a revocable trust, which reporting person and reporting person's wife are trustees and who with their children are beneficiaries of the Trust. These shares are held in the Trust for the benefit of reporting person and reporting person's wife and children. The reporting person and reporting person's wife are trustees of the Trust. The reporting person may be deemed to have an indirect pecuniary interest in the shares owned by the Trust. The reporting person disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that such reporting person is the beneficial owner of such securities for purposes of Section 16 or any other purposes.
  3. Exercise of options expiring on December 17, 2013.
  4. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $18.3700 to $18.50000. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  5. The option vested in six equal installments every six months beginning on June 17, 2004.